Repurposing Pilocarpine Hydrochloride for Treatment of Candida albicans Infections.

Animals Antifungal Agents / therapeutic use Candida albicans / cytology Candidiasis / drug therapy Cholinergic Agonists / therapeutic use Disease Models, Animal Drug Repositioning Immunologic Factors / therapeutic use Lepidoptera / drug effects Pilocarpine / therapeutic use Receptors, Cholinergic / metabolism Virulence / drug effects
Candida albicans Galleria mellonella biofilm muscarinic pilocarpine hydrochloride repurposing

Journal

mSphere
ISSN: 2379-5042
Titre abrégé: mSphere
Pays: United States
ID NLM: 101674533

Informations de publication

Date de publication:
23 01 2019
Historique:
entrez: 25 1 2019
pubmed: 25 1 2019
medline: 21 3 2019
Statut: epublish

Résumé

Acetylcholine modulates the virulence of

Identifiants

DOI: 10.1128/mSphere.00689-18 PMID: 30674648 PMC: PMC6344604
pubmed: 30674648
pii: 4/1/e00689-18
doi: 10.1128/mSphere.00689-18
pmc: PMC6344604
pii:
doi:

Substances chimiques

Antifungal Agents 0
Cholinergic Agonists 0
Immunologic Factors 0
Receptors, Cholinergic 0
Pilocarpine 01MI4Q9DI3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
ID : 097377/Z/11/Z
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/P504567/1
Pays : United Kingdom

Informations de copyright

Copyright © 2019 Nile et al.

Références

J Intern Med. 2009 Jun;265(6):663-79
pubmed: 19493060
J Pharmacol Sci. 2008 Feb;106(2):167-73
pubmed: 18285657
Shock. 2008 Oct;30(4):468-72
pubmed: 18391858
Eur J Histochem. 2014 Sep 23;58(3):2428
pubmed: 25308852
Int J Mol Sci. 2012;13(2):2219-38
pubmed: 22408449
Tissue Cell. 2016 Aug;48(4):297-304
pubmed: 27378036
FEMS Microbiol Lett. 1991 Jan 15;61(2-3):187-93
pubmed: 2037228
Front Biosci. 2004 Sep 01;9:2063-85
pubmed: 15353271
Immunology. 2010 Jul;130(3):388-98
pubmed: 20408892
Life Sci. 2005 Sep 2;77(16):1935-44
pubmed: 15936779
Microb Cell. 2018 Jun 14;5(7):300-326
pubmed: 29992128
Front Microbiol. 2012 Mar 29;3:116
pubmed: 22479260
Semin Arthritis Rheum. 2015 Dec;45(3):321-7
pubmed: 26216545
FEMS Microbiol Rev. 2008 Nov;32(6):1010-32
pubmed: 18811658
Life Sci. 2003 Feb 28;72(15):1745-56
pubmed: 12559395
Mol Pharmacol. 2006 Mar;69(3):1048-55
pubmed: 16365281
Antiinflamm Antiallergy Agents Med Chem. 2013;12(2):109-16
pubmed: 23360259
Int J Biochem Cell Biol. 2008;40(5):980-90
pubmed: 18083057
Mol Cell. 2014 Aug 7;55(3):422-435
pubmed: 24930733
Eukaryot Cell. 2015 Aug;14(8):834-44
pubmed: 26092919
J Immunol. 2010 Jan 1;184(1):401-10
pubmed: 19949071
Int Immunopharmacol. 2015 Nov;29(1):127-34
pubmed: 25907239
Front Microbiol. 2015 Oct 06;6:1077
pubmed: 26500623
Insect Biochem Mol Biol. 2002 Oct;32(10):1295-309
pubmed: 12225920
Nat Rev Immunol. 2011 Apr;11(4):275-88
pubmed: 21394104
Nature. 2007 Jan 4;445(7123):116-9
pubmed: 17167423
J Pharmacol Exp Ther. 2009 Jan;328(1):331-42
pubmed: 18824613
Cell Mol Life Sci. 2011 Mar;68(6):931-49
pubmed: 20953658
Platelets. 2011;22(5):390-5
pubmed: 21385097
Virulence. 2013 Feb 15;4(2):119-28
pubmed: 23302789
FEMS Microbiol Rev. 2004 Feb;28(1):101-12
pubmed: 14975532
Life Sci. 2007 May 30;80(24-25):2352-60
pubmed: 17512954
Nucleic Acids Res. 2012 Jan;40(Database issue):D667-74
pubmed: 22064862
J Pharmacol Exp Ther. 2007 Dec;323(3):963-71
pubmed: 17878406
CNS Neurol Disord Drug Targets. 2014;13(7):1294-303
pubmed: 25230223
Eur Respir J. 2013 Dec;42(6):1677-88
pubmed: 23397297
Mol Biol Cell. 2005 Apr;16(4):1971-86
pubmed: 15673611
Virulence. 2013 Oct 1;4(7):597-603
pubmed: 23921374
Shock. 2006 Oct;26(4):358-64
pubmed: 16980882
Life Sci. 2007 May 30;80(24-25):2361-4
pubmed: 17286990
Nat Chem Biol. 2011 Aug 28;7(10):740-7
pubmed: 21873996
J Histochem Cytochem. 2004 Nov;52(11):1427-35
pubmed: 15505337
J Antibiot (Tokyo). 2018 Mar;71(4):456-466
pubmed: 29348527
Life Sci. 2003 Mar 28;72(18-19):2055-61
pubmed: 12628456
J Insect Physiol. 2013 Jun;59(6):595-603
pubmed: 23557681
Curr Opin Investig Drugs. 2010 Nov;11(11):1239-45
pubmed: 21157643
J Med Microbiol. 2011 May;60(Pt 5):689-90
pubmed: 21273372
FEMS Yeast Res. 2015 Jun;15(4):fov016
pubmed: 25878052
Life Sci. 2007 May 30;80(24-25):2206-9
pubmed: 17363003
Cochrane Database Syst Rev. 2012 Sep 12;(9):CD004399
pubmed: 22972069
J Prosthodont. 2010 Jun;19(4):252-7
pubmed: 20113395
Genome Biol. 2005;6(1):R4
pubmed: 15642096
Med Mycol. 2014 Aug;52(6):555-64
pubmed: 25023483
Br J Pharmacol. 2008 Aug;154(8):1558-71
pubmed: 18500366

Auteurs

Christopher Nile (C)

Oral Sciences Research Group, University of Glasgow Dental School, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom christopher.nile@glasgow.ac.uk.

Monica Falleni (M)

Division of Human Pathology, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.

Daniela Cirasola (D)

Laboratory of Microbiology, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.

Abeer Alghamdi (A)

Oral Sciences Research Group, University of Glasgow Dental School, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Oliver F Anderson (OF)

Oral Sciences Research Group, University of Glasgow Dental School, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Christopher Delaney (C)

Oral Sciences Research Group, University of Glasgow Dental School, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Gordon Ramage (G)

Oral Sciences Research Group, University of Glasgow Dental School, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Emerenziana Ottaviano (E)

Laboratory of Microbiology, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.

Delfina Tosi (D)

Division of Human Pathology, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.

Gaetano Bulfamante (G)

Division of Human Pathology, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.

Giulia Morace (G)

Laboratory of Microbiology, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.

Elisa Borghi (E)

Laboratory of Microbiology, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.

Articles similaires

Evaluating the efficacy of telesurgery with dual console SSI Mantra Surgical Robotic System: experiment on animal model and clinical trials.

Sudhir Prem Srivastava, Vishwajyoti Pascual Srivastava, Avinesh Singh et al.
1.00
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

FBXO22 inhibits colitis and colorectal carcinogenesis by regulating the degradation of the S2448-phosphorylated form of mTOR.

Minle Li, Xuan Chen, Pengfei Qu et al.
1.00
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Use of organic material provided by an automatic enrichment device by weaner pigs and its influence on tail lesions.

Philipp Heseker, Jeanette Probst, Stefanie Ammer et al.
1.00
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Repurposing Pilocarpine Hydrochloride for...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antifongiques › Repurposing Pilocarpine Hydrochloride for...
questionsmedicales.fr › Eucaryotes › Champignons › Levures › Candida › Candida albicans › Repurposing Pilocarpine Hydrochloride for...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Mycoses › Candidose › Repurposing Pilocarpine Hydrochloride for...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Agents neuromédiateurs › Agents cholinergiques › Agonistes cholinergiques › Repurposing Pilocarpine Hydrochloride for...
questionsmedicales.fr › Techniques d'investigation › Modèles théoriques › Modèles biologiques › Modèles animaux de maladie humaine › Repurposing Pilocarpine Hydrochloride for...
questionsmedicales.fr › Techniques d'investigation › Développement de médicament › Repositionnement des médicaments › Repurposing Pilocarpine Hydrochloride for...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Facteurs immunologiques › Repurposing Pilocarpine Hydrochloride for...
questionsmedicales.fr › Eucaryotes › Animaux › Invertébrés › Arthropodes › Insectes › Pterygota › Neoptera › Holometabola › Lepidoptera › Repurposing Pilocarpine Hydrochloride for...
questionsmedicales.fr › Composés hétérocycliques › Alcaloïdes › Pilocarpine › Repurposing Pilocarpine Hydrochloride for...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs aux neuromédiateurs › Récepteurs cholinergiques › Repurposing Pilocarpine Hydrochloride for...
questionsmedicales.fr › Phénomènes microbiologiques › Virulence › Repurposing Pilocarpine Hydrochloride for...